Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Foscarnet-resistant cytomegalovirus esophagitis with stricturing.

Gaduputi V, Patel H, Vootla V, Khan U, Chilimuri S.

Case Rep Gastroenterol. 2013 Jan;7(1):25-9. doi: 10.1159/000342352. Epub 2013 Jan 10.

3.

Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection.

Boutolleau D, Canestri A, Burrel S, Wirden M, Seang S, Clavel-Osorio C, Marcelin AG, Katlama C, Agut H.

J Clin Virol. 2012 Jun;54(2):194-6. doi: 10.1016/j.jcv.2012.02.008. Epub 2012 Mar 6.

PMID:
22398036
5.

[CMV-induced duodenal papillitis in a patient with HIV-1 infection].

Minami R, Takahama S, Nakashima E, Yamamoto M.

Kansenshogaku Zasshi. 2013 Jul;87(4):441-5. Japanese.

PMID:
23984594
7.

Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.

Ries E, Mühlbauer B, Ruhswurm I, Krepler K, Derbolav A, Svolba G, Rieger A, Wedrich A.

Ophthalmologica. 1998;212(4):239-43.

PMID:
9672212
9.
10.

Cytomegalovirus and Candida esophagitis in patients with AIDS.

Laine L, Bonacini M, Sattler F, Young T, Sherrod A.

J Acquir Immune Defic Syndr. 1992;5(6):605-9.

PMID:
1316961
12.

Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet.

Blanshard C.

J Acquir Immune Defic Syndr. 1992;5 Suppl 1:S25-8.

PMID:
1318364
13.

Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.

Jacobson MA, Drew WL, Feinberg J, O'Donnell JJ, Whitmore PV, Miner RD, Parenti D.

J Infect Dis. 1991 Jun;163(6):1348-51.

PMID:
1645385
14.

Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.

Wutoh AK, Hidalgo J, Rhee W, Bareta J, Steidl S.

Am J Health Syst Pharm. 1999 Jul 1;56(13):1314-8.

PMID:
10683128
15.

Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA.

Ohta H, Matsuda Y, Tokimasa S, Sawada A, Kim JY, Sashihara J, Amo K, Miyagawa H, Tanaka-Taya K, Yamamoto S, Tano Y, Aono T, Yamanishi K, Okada S, Hara J.

Bone Marrow Transplant. 2001 Jun;27(11):1141-5.

16.

The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.

Manfredi R, Mastroianni A, Coronado OV, Chiodo F.

Recenti Prog Med. 1996 Nov;87(11):545-8.

PMID:
9122537
17.

Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.

Dunn JP, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA.

Am J Ophthalmol. 1995 May;119(5):587-96.

PMID:
7733184
18.

Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.

Jabs DA.

Infect Agents Dis. 1995 Sep;4(3):131-42. Review.

PMID:
8548191
19.

Intravitreal and systemic foscarnet in the treatment of AIDS-related CMV retinitis.

Tognon MS, Turrini B, Masiero G, Scaggiante R, Cadrobbi P, Baldanti F, Gerna G, Secchi AG.

Eur J Ophthalmol. 1996 Apr-Jun;6(2):179-82.

PMID:
8823593
20.

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.

J Infect Dis. 1998 Apr;177(4):1080-3.

Items per page

Supplemental Content

Write to the Help Desk